Cargando…
Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
Antiangiogenic therapy is a universal approach to the treatment of malignant gliomas but fails to prolong the overall survival of newly diagnosed or recurrent glioblastoma patients. Imaging biomarkers are quantitative imaging parameters capable of objectively describing biological processes, patholo...
Autores principales: | Kong, Ziren, Yan, Chengrui, Zhu, Ruizhe, Wang, Jiaru, Wang, Yaning, Wang, Yu, Wang, Renzhi, Feng, Feng, Ma, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067083/ https://www.ncbi.nlm.nih.gov/pubmed/30069427 http://dx.doi.org/10.1016/j.nicl.2018.07.001 |
Ejemplares similares
-
Molecular biomarker‐guided anti‐angiogenic targeted therapy for malignant glioma
por: Yan, Chengrui, et al.
Publicado: (2019) -
(18)F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
por: Kong, Ziren, et al.
Publicado: (2019) -
Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021) -
Pretreatment Geriatric Assessments of Elderly Patients with Glioma: Development and Implications
por: Wang, Yaning, et al.
Publicado: (2020) -
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
por: Plate, Karl H., et al.
Publicado: (2012)